NAS:AMRN (Ireland)
Â
Business Description
Amarin Corp PLC
NAICS : 325412
SIC : 2834
Description
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 30.6 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Altman Z-Score | -0.19 | |||||
| Beneish M-Score | -0.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.4 | |||||
| 3-Year FCF Growth Rate | 19.7 | |||||
| 3-Year Book Growth Rate | 61.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.43 | |||||
| 9-Day RSI | 65.55 | |||||
| 14-Day RSI | 65.55 | |||||
| 6-1 Month Momentum % | 11.63 | |||||
| 12-1 Month Momentum % | -60.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.39 | |||||
| Quick Ratio | 1.6 | |||||
| Cash Ratio | 1.06 | |||||
| Days Inventory | 706.6 | |||||
| Days Sales Outstanding | 119.05 | |||||
| Days Payable | 272.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.8 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.13 | |||||
| Operating Margin % | -15.79 | |||||
| Net Margin % | -21.72 | |||||
| ROE % | -14.74 | |||||
| ROA % | -9.27 | |||||
| ROIC % | -26.86 | |||||
| ROC (Joel Greenblatt) % | -84.74 | |||||
| ROCE % | -12.16 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.32 | |||||
| PB Ratio | 1.5 | |||||
| Price-to-Tangible-Book | 1.56 | |||||
| EV-to-EBIT | -6.15 | |||||
| EV-to-EBITDA | -6.4 | |||||
| EV-to-Revenue | 1.16 | |||||
| EV-to-Forward-Revenue | 1.46 | |||||
| EV-to-FCF | -2.33 | |||||
| Price-to-Net-Current-Asset-Value | 2.41 | |||||
| Earnings Yield (Greenblatt) % | -16.26 |
How Amarin Corp PLC (AMRN) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AMRN
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
Details
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 423.439 | ||
| EPS (TTM) ($) | -0.23 | ||
| Beta | 2.13 | ||
| Volatility % | 79.93 | ||
| 14-Day RSI | 65.55 | ||
| 14-Day ATR ($) | 0.119427 | ||
| 20-Day SMA ($) | 1.843 | ||
| 12-1 Month Momentum % | -60.66 | ||
| 52-Week Range ($) | 1.04 - 3.815 | ||
| Shares Outstanding (Mil) | 403.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Amarin Corp PLC Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Amarin Corp PLC Stock Events
| Event | Date | Price($) | Daily Change % | ||
|---|---|---|---|---|---|
| No Event Data | |||||
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||